BONE MINERAL METABOLISM AND ITS RELATIONSHIP TO LEPTIN LEVELS IN SURVIVORS OF CHILDHOOD LEUKEMIA AND LYMPHOMA

REFERENCES

• Craft A W. Childhood cancer—mainly curable so where next?. Acta Pediatr 2000; 89: 386–392, [CSA]
   PubMedGoogle Scholar
• Meister L A, Meadows A T. Late effects of childhood cancer. Curr Probl Pediatr 1993; 23: 102–131, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Shalet S M. Endocrine sequel of cancer therapy. Eur J Endocrinol 1996; 135: 135–143, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Leiper A D. Osteoporosis in survivors of childhood malignancy. Eur J Cancer 1998; 34: 770–772, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Google Scholar
• Arikoski P, Voutilainen R, Kroger H. Bone mineral density in long term survivors of childhood cancer. J Pediatr Endocrinol Metab 2003; 16(Suppl 2)343–353, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Huang L, Li C. Leptin: a multifunctional hormone. Cell Res 2000; 10: 81–92, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rivera G K, Pui C H, Hancock M L, et al. Update of St Jude XI for childhood acute lymphoblastic leukemia. Leukemia. 1992; 6: 153–156, [PUBMED], [INFOTRIEVE], [CSA]
   Google Scholar
• Büyükpamukçu M, Sarialio_lu F, Akyüz C, Çevik N. Combined chemotheraphy in 76 children with non-Hodgkin's lymphoma excluding Burkitt lymphoma. Br J Cancer 1987; 56: 625–628, [CSA]
   PubMed Web of Science ®Google Scholar
• Murphy S B, Bowman W P, Abromowitch M, et al. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol. 1986; 4: 1732–1739, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• World Health Organization. Measuring Change in Nutritional Status. WHO, Geneva 1983
   Google Scholar
• Waterlow J C. Classification and definition of protein calorie malnutrition. Br J Med 1972; 3: 566–569, [CSA]
   PubMed Web of Science ®Google Scholar
• Gomez F, Galvan R R, Frank S, et al. Mortality in second and third degree malnurition. J Trop Pediar. 1956; 2: 77–81, [CSA]
   Google Scholar
• Wheeler M D. Physical changes of puberty. Endocrinol Metab Clin North Am 1991; 20: 1–14, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Tanyer G, Topcu M, Síklar Z, et al. Iki-onalti yasarasi sag líklí çocuklarda kemik mineral yogunlugunun degerlendirilmesi. Klin Bilimler Doktor 1998; 4: 733–742, [CSA]
   Google Scholar
• Leonard M B, Propert K J, Zemel B S, et al. Discrepancies in pediatric bone mineral density reference data: potential for misdiagnosis of osteopenia. J Pediatr 1999; 135: 182–188, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Fassler A LC, Bonjour J P. Osteoporosis as a pediatric problem. Pediatr Clin North Am 1995; 42: 811–824, [CSA]
   PubMedGoogle Scholar
• Halton J M, Atkinson S A, Fraher L, et al. Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J Pediatr. 1995; 126: 557–564, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Atkinson S A, Halton J M, Bradley C, et al. Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition. Int J Cancer 1998, Suppl 11: 35–39, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Crofton P M, Ahmed S F, Wade J C, et al. Effects of intensive chemotherapy on bone and collagen turnover and growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metabol. 1998; 83: 3121–3129, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Davies J H, Evans B A, Jones E, Evans W D, JJenney M EM, Gregory J W. Osteopenia excess adiposity and hyperleptinemia during 2 years of treatment for childhood acute lymphoblastic leukemia without cranial irradiation. Clin Endocrinol 2004; 60: 358–365, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Arioski P, Komulainen J, Voutilainen R, et al. Reduced bone mineral density in long-term survivors of childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol. 1998; 20: 2134–2240, [CSA]
   Google Scholar
• Nysom K, Holm K, Michaelsen K F, et al. Bone mass treatment for acute lymphoblastic leukemia in childhood. J Clin Oncol. 1998; 16: 3752–3760, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Kreipe R E. Bone mineral density in adolescent. Pediatr Ann 1995; 24: 308–315, [PUBMED], [INFOTRIEVE]
   Google Scholar
• Jilka R L. Biology of the basic multicellular unit and pathophysiology of osteoporosis. Med Pediatr Oncol 2003; 41: 182–185, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Tomasi M, Bacciottini L, Benucci A, et al. Serum biochemical marker of bone turnover in healthy infants and children. Int J Biol Marker. 1996; 11: 159–164
   Google Scholar
• Olney R C. Regulation of bone mass by growth hormone. Med Pediatr Oncol 2003; 41: 228–234, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Mukherjee A, Shalet S M. Growth hormone replacement therapy in children and adolescents: skeletal impact. Med Pediatr Oncol 2003; 41: 235–242, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Rehman Q, Lane N E. Effect of glucocorticoids on bone density. Med Pediatr Oncol 2003; 41: 208–211, [CROSSREF]
   Google Scholar
• Swartz A M, Leonidas J C. Methotrexate osteopathy. Skeletal Radiol 1984; 11: 13–16, [CROSSREF]
   Google Scholar
• Mandel K, Atkinson S, Barr R D, Pencharz P. Skeletal morbidity in childhood acute lymphoblastic leukemia. J Clin Oncol 2004; 22: 1215–1221, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Argüelles B, Barrios V, Buno M, et al. Anthropometric parameters and their relationship to serum growth hormone-binding protein and leptin in children with acute lymphoblastic leukemia: a prospective study. Eur J Endocrinol. 2000; 143: 243–250, [CROSSREF]
   Google Scholar
• Brennan B M, Rahim A, Blum W F, et al. Hyperleptinemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity. Clin Endocrinol. 1999; 50: 163–169, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wallace A M, Tucker P, Williams D M, et al. Short term effects of prednisolone and dexamethasone on circulating concentrations of leptin and sex hormone-binding globulin in children being treated for acute lymphoblastic leukemia. Clin Endocrinol. 2003; 58: 770–776, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Siomons J P, Schols A M, Campfield L A, et al. Plasma concentration of total leptin and human lung- cancer associated cachexia. Clin Sci. 1997; 93: 273–277
   Google Scholar
• Arpaci F, Yilmaz M I, Ozet A, et al. Low serum leptin level in colon cancer patients without significant weight loss. Tumori. 2002; 88: 147–149, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Whipple T, Sharkey N, Demers L, Williams N. Leptin and skeleton. Clin Endocrinol 2002; 57: 701–711, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Thomas T, Burguera B. Is leptin link between fat and bone mass. J Bone Mineral Res 2002; 17: 1563–1569
   PubMed Web of Science ®Google Scholar
• Gordeladze J O, Reseland J E. A unified model for action of leptin on bone turnover. J Cell Biochem 2003; 88: 706–712, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lee Y J, Park J H, Ju S K, et al. Leptin receptor isoform expression in rat osteoblasts and their functional analysis. FEBS Lett. 2002; 528: 43–47, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gordeladze J O, Drevon C A, Syversen U, Reseland J E. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis and mineralization: impact on differentiation markers, apoptosis and osteoclastic signaling. Cell Biochem 2002; 85: 825–836, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Holloway W, Collier F M, Aitken C, et al. Leptin inhibits osteoclast generation. J Bone Miner Res. 2002; 17: 200–209, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Reseland J E, Gordeladz J O. Role of leptin in bone growth: central player or peripheral supporter. FEBS Lett 2002; 528: 40–42, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Iwamoto I, Douchi T, Koksa S. Relationships between serum leptin level and regional bone mineral density, bone metabolic markers in healthy women. Acta Obstet Gynecol Scand 2000; 79: 1060–1064, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zoico E, Zamboni M, Adami S. Relationship between leptin levels and bone mineral density in elderly. Clin Endocrinol 2003; 59: 97–103, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hadji P, Bock K, Gotschalk M, et al. The influence of serum leptin concentration on bone mass assessed by quantitative ultrasonometry in pre and postmenopausal women. Maturitas 2003; 44: 141–148, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ruhl C E, Everhart J E. Relationship of serum leptin concentration with bone mineral density in the United States population. J Bone Miner Res 2002; 17: 1896–1903, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Matkovic V, Ilich J Z, Skugor M, et al. Leptin is inversely related to age at menarche in human females. J Clin Endocrinol Metab. 1997; 82: 3239–3245, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Roemmich J N, Clark P A, Mantzoros C S, et al. Relationship of leptin to bone mineralization in children and adolescents. J Clin Endocrinol Metab. 2003; 88: 599–604, [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Huang K C, Cheng W C, Yen R F, et al. Lack of independent relationship between plasma adiponectin, leptin levels and bone density in nondiabetic female. Clin Endocrinol 2004; 61: 204–208, [CROSSREF]
   PubMed Web of Science ®Google Scholar